Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Landis Insider Profile
4 Followers
John Landis, Director at Bioanalytical Systems, holds 40.00K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 30.00K shares in Bioanalytical Systems (Ticker: BASI). Most recently, John Landis Bought ― shares of EyePoint Pharmaceuticals on May 15, 2019 for an estimated value of 69.60K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-25.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Landis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 20, 2012 - Aug 20, 2013
Return:+5.90%
The most profitable trade made by John Landis
John Landis's Trading History
Bioanalytical Systems
Aug 20, 2012
Director
Informative Buy
37.80K
$194.40K
EyePoint Pharmaceuticals
May 15, 2019
Director
Informative Buy
69.60K
$21.56K
List of latest transactions for each holding click on a transaction to see John Landis's performance on stock
You May Also Like
John Landis insider profile FAQ
What is the percentage of profitable transactions made by John Landis?
The percentage of profitable transactions made by John Landis is 50%.
What is the average return per transaction made by John Landis?
The average return per transaction made by John Landis is -25.10%.
What stocks does John Landis hold?
John Landis holds: BASI, EYPT stocks.
What was John Landis’s latest transaction?
John Landis latest transaction was an Informative Buy of $69.60K.
What was John Landis's most profitable transaction?
John Landis’s most profitable transaction was an Informative Buy of BASI stock on August 20, 2012. The return on the trade was 5.90%.
What is John Landis's role in Bioanalytical Systems?
John Landis's role in Bioanalytical Systems is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.